Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Edwards Lifesciences Corp (EW)

  • Business News
  • Nov. 09, 2025, 21:02 UTC
  • 9
  • 0 comments

Edwards Lifesciences Corp - Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease

Market reaction Comment Full text

Edwards Lifesciences Corp (EW)

  • Business News
  • Nov. 09, 2025, 21:00 UTC
  • 19
  • 1 comments

Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 09, 2025, 20:54 UTC
  • 16
  • 1 comments

What Is Microsoft Edge?

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 09, 2025, 20:52 UTC
  • 19
  • 1 comments

RTX 5080: Latest Info, Specs, and Updates (November 2025)

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 09, 2025, 20:24 UTC
  • 23
  • 1 comments

Silent Hill 2 Remake: Latest News, Release Date, and Everything We Know

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 09, 2025, 20:23 UTC
  • 23
  • 1 comments

Latest About Palworld (November 2025)

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 09, 2025, 20:21 UTC
  • 28
  • 1 comments

How to Split Screen on Chromebook

Market reaction Comment Full text

Monopar Therapeutics Inc. (MNPR)

  • Business News
  • Nov. 09, 2025, 14:00 UTC
  • 23
  • 1 comments

Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025

Market reaction Comment Full text

Nektar Therapeutics (NKTR)

  • Business News
  • Nov. 08, 2025, 22:45 UTC
  • 34
  • 1 comments

New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting

Market reaction Comment Full text

Vertex Pharmaceuticals (VRTX)

  • Business News
  • Nov. 08, 2025, 22:15 UTC
  • 31
  • 1 comments

Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week

Market reaction Comment Full text
  • Previous
  • 741
  • 742
  • 743
  • 744
  • 745
  • Next

Search

News categories

  • Technical Exchange News(10969)
  • Event(2441)
  • SEC News(193597)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125910)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin